UCP2 and Abnormal retinal morphology: Regardless, a larger study of Ucp2 and PPAR-γ in retinal disease that uses multiple models and agonists/antagonists may yield a clearer picture that captures the cell type specific dynamics of these factors, and changes during different paradigms of retinal damage.